The administration of sulforaphane to rats with AD-like symptoms produced by Aβ resulted in a decrease in neuroinflammation, as evidenced by reductions in the levels of TNF-α and IL-1β (Hou et al. 2018; Wang et al. 2020). The gene discussed is IL1B; the disease is Alzheimer disease.